Of all people... I never would have guessed... ... ...
| |
Dear Reader,
Of all people, I never would have guessed Dave Lashmet…
Dave's our biotech expert.
He's the editor of our most elite and expensive research service, Stansberry Venture.
Dave's a shy guy.
He lives on a remote island off the coast of Washington that's typically only accessible by ferryboat.
So I was surprised to receive a video message from Dave last week telling me how excited he was about our "Melt Up Millionaire" Project.
Dave said, "I think what Steve has to say about the end of a bull market is pretty awesome… so I'm on his side not Porter's."
Dave even allowed us to use one of his biotech recommendations for our model portfolio. (Typically, you'd pay $5,000 for a recommendation like this).
I can't say much about it here, but I will tell you this…
It's a pharmaceutical stock with a current market cap of $1 billion…
Dave believes that if the company's drug clears its upcoming Phase 3 trial with the FDA, it could easily be worth $10 billion.
(And it's been 95% successful with patients who used it so far…)
Steve and Dave think this one stock could easily return hundreds of percent very quickly.
And it's just one of the investments in our new "Melt Up Millionaire" model portfolio.
Remember, we're swinging for the fences with this new project.
Our goal is to return weighted gains of at least 100% in the next 12 months.
If not, you get full credit back… plus a free year of our work… guaranteed.
The only catch is you must start building your positions soon if you expect to see these gains…
And we'll only extend discounted access for new members for a limited time.
To learn more about the "Melt Up Millionaire" Project, click here.
Regards, Brett Eversole
Senior Analyst, Stansberry Research
|
|
| |
All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to info@stansberrycustomerservice.com.
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
